The scale might read the same for a few days while your waistband tells a different story
People Love the Ease of Zepbound in Temecula Users love the fact that it tackles weight loss comprehensively
That is what we have started this week with tirzepatide. Trial protocols call for half of the 1,000 participants to receive a placebo, inert doses that have no effect, rather than the active drug, creating a control group that is critical to obtaining scientifically valid results
Some commonly reported effects after stopping Semaglutide include: Increased appetite or hunger Gradual weight regain Higher blood sugar levels (especially in the case of Diabetes) Reduced feelings of fullness after meals Return of food cravings Changes in energy levels Most of these effects are related to the loss of Semaglutides therapeutic action rather than true withdrawal symptoms
References NHS England: Implementation of NICE TA1026 for Tirzepatide (Mounjaro) NHS England: Medicines for obesity Focus On: Tirzepatide for Weight Management in General Practice (2025) Senedd Research: What next for weight-loss medication in Wales
People should contact their health care provider if they feel any symptoms